Filing Details
- Accession Number:
- 0001628280-24-045328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-05 16:38:00
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-11-05 16:38:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-01 | 309 | $1.27 | 256,800 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-02 | 309 | $1.29 | 257,109 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-03 | 309 | $1.28 | 257,418 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-04 | 309 | $1.28 | 257,727 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-07 | 309 | $1.29 | 258,036 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-08 | 309 | $1.30 | 258,345 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-09 | 309 | $1.31 | 258,654 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-10 | 309 | $1.32 | 258,963 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-11 | 309 | $1.39 | 259,272 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-14 | 309 | $1.37 | 259,581 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-15 | 309 | $1.30 | 259,890 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-16 | 309 | $1.25 | 260,199 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-17 | 309 | $1.30 | 260,508 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-18 | 309 | $1.28 | 260,817 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-21 | 309 | $1.25 | 261,126 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-22 | 309 | $1.25 | 261,435 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-23 | 309 | $1.26 | 261,744 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-24 | 309 | $1.24 | 262,053 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-25 | 309 | $1.23 | 262,362 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-28 | 309 | $1.25 | 262,671 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-29 | 309 | $1.24 | 262,980 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-30 | 309 | $1.32 | 263,289 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-31 | 309 | $1.20 | 263,598 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
